National Centre for Vector Borne Diseases Control (NCVBDC)

National Centre for Vector Borne Diseases Control (NCVBDC) : According to the National Centre for Vector Borne Diseases Control (NCVBDC), India has made notable strides in malaria control, recording an over 80% decline in cases between 2015 and 2023.

o However, the disease continues to linger in tribal and forested areas, with districts like Lawngtlai in Mizoram and Narayanpur in Chhattisgarh still reporting high incidence rates of 56 and 22 cases per 1,000 population, respectively.

• About Malaria : A potentially fatal febrile disease caused by Plasmodium parasites, transmitted through the bite of infected female Anopheles mosquitoes. While not contagious, it can also spread via infected blood or contaminated needles.

  o Symptoms: Usually appear 10–15 days after infection and include fever, chills, and headache. In severe cases, it can lead to seizures, jaundice, breathing difficulties, or death, with partial immunity in endemic areas making diagnosis harder.

  • Approved & Advanced-Stage Vaccines: RTS,S (Mosquirix) and R21/Matrix-M
  • Next-Generation Vaccine: Whole-Parasite Vaccines (PfSPZ, PfSPZ-LARC2), Blood-Stage Vaccine (PfRH5) and India’s AdFalciVax.
  • About NCVBDC: Implements the National Vector Borne Diseases Control Programme (NVBDCP).

  üThe programme aims to prevent and control six major vector-borne diseases: Malaria, Japanese Encephalitis, Dengue, Chikungunya, Kala-azar and Lymphatic Filariasis